Case Report
Accepted on 26 Feb 2026
Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report
in Gynecological Oncology
Case Report
Accepted on 26 Feb 2026
in Gynecological Oncology
Systematic Review
Accepted on 26 Feb 2026
in Health Technology Implementation
Review
Accepted on 26 Feb 2026
in Safe and Just Resource Management
Original Research
Accepted on 26 Feb 2026
in Pharmacology of Infectious Diseases
Original Research
Accepted on 26 Feb 2026
in Pharmacology of Infectious Diseases
Editorial
Accepted on 26 Feb 2026
in Reproductive Epidemiology
Original Research
Accepted on 26 Feb 2026
in Mechanics of Materials
Mini Review
Accepted on 26 Feb 2026
in Energy Materials
Original Research
Accepted on 26 Feb 2026
in Brain Imaging and Stimulation
Original Research
Accepted on 26 Feb 2026
in Cognitive Neuroergonomics
Original Research
Accepted on 26 Feb 2026
in Microbe and Virus Interactions with Plants
Original Research
Accepted on 26 Feb 2026
in Neurocritical and Neurohospitalist Care
Original Research
Accepted on 26 Feb 2026
in Life-Course Epidemiology and Social Inequalities in Health
Review
Accepted on 26 Feb 2026
in Plant Abiotic Stress
Review
Accepted on 26 Feb 2026
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 26 Feb 2026
in Pediatric Gastroenterology, Hepatology and Nutrition